Dihexa 1401708 83 5 BGC70883 Biosynth The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York DIHEXA PEPTIDE 10MG VIAL UMBRELLA Labs DIHEXA Research Capsules Peptide Tech Dihexa (also known as PNB 0408) is an experimental small molecule derived from angiotensin IV. It was engineered to cross the bloodbrain barrier and has shown synaptogenic effects in preclinical models. The often quoted Peptide Therapy Denver Original glam